Evidence map›Paper›PMID 42320460›Full record

ArticleBioorganic & medicinal chemistry2026

Sequence specificity of peptide nucleic acids containing terminal cationic amino acids.

Simeon O Kwange, Rambabu Dakarapu, Sarah L Wicks, Dev P Arya

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Simeon O KwangeNUBAD LLC, Greer, SC 29650, USA.
Rambabu DakarapuNUBAD LLC, Greer, SC 29650, USA.
Sarah L WicksNUBAD LLC, Greer, SC 29650, USA.
Dev P AryaNUBAD LLC, Greer, SC 29650, USA; Department of Chemistry, Clemson University, Clemson, SC 29634, USA. Electronic address: dparya@clemson.edu.

Funding

Development of peptide nucleic acid antibiotics-supplement 1R42AI114114 · NIAID · NUBAD, LLC · PI ARYA, DEV PRIYA · 2021 to 2024
$3.2M
Development of Peptide Antibiotic Nucleic AcidsR41AI114114 · NIAID · NUBAD, LLC · PI ARYA, DEV PRIYA · 2014 to 2015
$595k
NIAID NIH HHS R41 AI114114NIAID NIH HHS R42 AI114114
6 · The paper itself

Abstract

Molecular recognition of DNA/RNA by peptide nucleic acids (PNAs) has proven to be a successful strategy to create research and diagnostic tools. An ongoing challenge in the development of useful PNAs has been optimizing sequence specificity. Aside from the complement Watson-Crick base pair, stable mismatched base pairs can hinder sequence specificity of PNAs. Thus, there is a need to fine-tune the binding properties of PNAs so that off-target hybridization is minimized. In this study, the sequence specificity of four PNAs chemically modified at a terminal end with a positively charged amino acid was investigated. Melting temperatures for each PNA hybridized to complementary single-stranded (ss) DNA and RNA were determined and compared to those obtained for PNA•DNA/RNA hybrids containing a single base mismatch. Of the hybrids evaluated, cationic PNAs had improved sequence specificity compared to the ssDNA control against single base mismatches in DNA. The identity of the base(s) neighboring the positive charge of the PNA as well as the mismatch site of the DNA impacted the extent of discrimination. Additionally, sequence specificity of cationic PNAs was tunable by varying ionic conditions. The insights gained herein are valuable and can be leveraged for the design and success of future PNA probes.

Indexed as

Amino AcidsPeptide Nucleic AcidsBase Pair MismatchBase SequenceCationsDNADNA, Single-StrandedNucleic Acid HybridizationRNATransition TemperatureAmino AcidsCationsDNADNA, Single-StrandedPeptide Nucleic AcidsRNADNAMolecular recognitionPeptide nucleic acidsRNASequence specificityThermal denaturation

Identifiers

PMID42320460
PMCPMC13528810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.